Ixekizumab Diabetes Intervention Trial (I-DIT)

Clinical trial NCT04589325 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04589325
Sponsor: Göteborg University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type1 Diabetes Mellitus

Start date: 2022-11-09
Primary completion: 2027-02-01
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.